ENDRA Life Sciences (NDRA) Cash from Operations Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Cash from Operations Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.74% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 13.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.42% |
| Dec 31, 2025 | -6.33% |
| Sep 30, 2025 | 29.76% |
| Jun 30, 2025 | 46.54% |
| Mar 31, 2025 | 39.69% |
| Dec 31, 2024 | 30.30% |
| Sep 30, 2024 | 36.23% |
| Jun 30, 2024 | 8.17% |
| Mar 31, 2024 | 14.46% |
| Dec 31, 2023 | 29.60% |
| Sep 30, 2023 | 19.96% |
| Jun 30, 2023 | 31.98% |
| Mar 31, 2023 | 19.10% |
| Dec 31, 2022 | -16.43% |
| Sep 30, 2022 | -18.21% |
| Jun 30, 2022 | -19.13% |
| Mar 31, 2022 | -6.00% |
| Dec 31, 2021 | -27.96% |
| Sep 30, 2021 | -28.75% |
| Jun 30, 2021 | 18.90% |